banner

Investors

At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

10/26/20
SAN DIEGO --(BUSINESS WIRE)--Oct. 26, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that scientific presentations highlighting new analyses of pimavanserin clinical study data in dementia-related psychosis and neurodegenerative diseases will be shared at the 13 th Clinical
10/21/20
Acadia to Host Conference Call and Webcast on Wednesday, November 4, 2020 , at 4:30 p.m. Eastern Time   SAN DIEGO --(BUSINESS WIRE)--Oct. 21, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Wednesday, November 4, 2020 , after
10/14/20
ATLANTA & SAN DIEGO --(BUSINESS WIRE)--Oct. 14, 2020-- The Lewy Body Dementia Association (LBDA) and Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today an exclusive partnership on the production and release of a disease education adaptation of the new film Robin’s Wish © , a documentary